Amantadine therapy in renal transplant patients with hepatitis C virus infection
- 31 May 2004
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 30 (1), 110-114
- https://doi.org/10.1016/j.jcv.2003.10.001
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: A placebo-controlled trialJournal of Hepatology, 2003
- Pretransplant Interferon Prevents Hepatitis C Virus-Associated Glomerulonephritis in Renal Allografts by HCV-RNA ClearanceAmerican Journal of Transplantation, 2003
- The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, AmantadineFEBS Letters, 2002
- Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infectionGastroenterology, 2002
- Interferon and amantadine in naive chronic hepatitis C: A double-blind, randomized, placebo-controlled trialJournal of Hepatology, 2002
- Sustained Virological and Histological Response with Pretransplant Interferon Therapy in Renal Transplant Patients with Chronic Viral Hepatitis CAmerican Journal of Nephrology, 2001
- RETROSPECTIVE STUDY ON THE IMPACT OF HEPATITIS C VIRUS INFECTION ON KIDNEY TRANSPLANT PATIENTS OVER 20 YEARSTransplantation, 1998
- THE HIGH PREVALENCE OF SEVERE EARLY POSTTRANSPLANT RENAL ALLOGRAFT PATHOLOGY IN HEPATITIS C POSITIVE RECIPIENTSTransplantation, 1996
- An algorithm for the grading of activity in chronic hepatitis CJournal of Hepatology, 1996
- Clinical Pharmacokinetics of Amantadine HydrochlorideClinical Pharmacokinetics, 1988